Institut des Maladies Neurodégénératives (IMN)

L’Institut des Maladies Neurodégénératives (IMN) (UMR 5293) est une Unité Mixte de Recherche associant l’Université de Bordeaux et le CNRS. Il regroupe 11 équipes de recherches fondamentale et préclinique et d’une équipe de Recherche clinique adossée au CHU de Bordeaux. L’IMN associe recherche fondamentale, préclinique et clinique dans le but de :

-Développer de nouvelles approches thérapeutiques des maladies neurodégénératives en facilitant la recherche translationnelle du laboratoire au lit du patient.

-D’accroître sa visibilité et son attractivité dans le champ des neurosciences translationnelles (Maladie de Parkinson et syndromes parkinsoniens atypiques, maladie d’Alzheimer, troubles obsessionnels compulsifs, etc.) et fondamentales (planification, cognition, contrôle moteur, substrats moléculaires de la transmission synaptique) en s’appuyant sur le potentiel de ses équipes et la dynamique mise en place depuis sa création.

Site Web

Lien scanR

	2021	2022	2023	2024	2025
Actes de congrès/Proceedings	0	0	0	0	0
Article de blog scientifique	0	0	0	0	0
Article de revue	12	12	20	26	4
Autre document	0	0	0	0	0
Brevet	0	0	0	0	0
Chapitre d'ouvrage	0	0	0	0	0
Communication dans un congrès	0	0	0	0	0
Document de travail - Pré-publication	0	0	1	0	0
HDR	0	0	0	0	0
Notice d'encyclopédie ou de dictionnaire	0	0	0	0	0
N°spécial de revue/special issue	0	0	0	0	0
Ouvrage	0	0	0	0	0
Poster	0	0	0	0	0
Rapport	0	0	0	0	0
Thèse d'exercice	0	0	0	0	0
Thèses de doctorat	4	2	0	0	0
Traduction	0	0	0	0	0

Institut des Maladies Neurodégénératives (IMN) - UMR 5293

Listar por

Envíos recientes

Deep learning disconnectomes to accelerate and improve long-Term predictions for post-stroke symptoms

In vivo bioluminescence imaging of the intracerebral fibroin-controlled AAV-α-synuclein diffusion for monitoring the central nervous system and peripheral expression

Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project

Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers

Genetic labeling of embryonically-born dentate granule neurons in young mice using the PenkCre mouse line

Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis

Resting state connectivity patterns associated with trait anxiety in adolescence

Statistical harmonization of versions of measures across studies using external data: Self-rated health and self-rated memory

Amantadine use in the French prospective NS-Park cohort

SHIVA-CMB: a deep-learning-based robust cerebral microbleed segmentation tool trained on multi-source T2*GRE- and susceptibility-weighted MRI

Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries.

Adverse childhood experiences and left hippocampal volumetric reductions: A structural magnetic resonance imaging study

GAP43 Located on Corticostriatal Terminals Restrains Novelty-Induced Hyperactivity in Mice

Are we ready to cure post-stroke cognitive impairment? Many key prerequisites can be achieved quickly and easily

Explaining the Variability of Alzheimer Disease Fluid Biomarker Concentrations in Memory Clinic Patients Without Dementia

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort

Trial of Lixisenatide in Early Parkinson’s Disease

Diffusion imaging genomics provides novel insight into early mechanisms of cerebral small vessel disease

Association of LIfestyle for BRAin health risk score (LIBRA) and genetic susceptibility with incident dementia and cognitive decline

Genetic variants for head size share genes and pathways with cancer

Estadísticas

Estadísticas generales de la colección

Historial de tipología de registros

Distribución de envíos recientes

Institut des Maladies Neurodégénératives (IMN) - UMR 5293

Listar por

Envíos recientes

Deep learning disconnectomes to accelerate and improve long-Term predictions for post-stroke symptoms ﻿

In vivo bioluminescence imaging of the intracerebral fibroin-controlled AAV-α-synuclein diffusion for monitoring the central nervous system and peripheral expression ﻿

Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project ﻿

Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers ﻿

Genetic labeling of embryonically-born dentate granule neurons in young mice using the PenkCre mouse line ﻿

Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis ﻿

Resting state connectivity patterns associated with trait anxiety in adolescence ﻿

Statistical harmonization of versions of measures across studies using external data: Self-rated health and self-rated memory ﻿

Amantadine use in the French prospective NS-Park cohort ﻿

SHIVA-CMB: a deep-learning-based robust cerebral microbleed segmentation tool trained on multi-source T2*GRE- and susceptibility-weighted MRI ﻿

Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries. ﻿

Adverse childhood experiences and left hippocampal volumetric reductions: A structural magnetic resonance imaging study ﻿

GAP43 Located on Corticostriatal Terminals Restrains Novelty-Induced Hyperactivity in Mice ﻿

Are we ready to cure post-stroke cognitive impairment? Many key prerequisites can be achieved quickly and easily ﻿

Explaining the Variability of Alzheimer Disease Fluid Biomarker Concentrations in Memory Clinic Patients Without Dementia ﻿

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort ﻿

Trial of Lixisenatide in Early Parkinson’s Disease ﻿

Diffusion imaging genomics provides novel insight into early mechanisms of cerebral small vessel disease ﻿

Association of LIfestyle for BRAin health risk score (LIBRA) and genetic susceptibility with incident dementia and cognitive decline ﻿

Genetic variants for head size share genes and pathways with cancer ﻿